---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-045212"
form_type: "8-K"
ticker: null
cik: "0001614067"
company_name: "Aridis Pharmaceuticals, Inc."
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:19:08.025833+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aridis Pharmaceuticals amends bylaws to set stockholder meeting quorum at 33.33%

## Summary
- Board approved quorum reduction to one-third (33.33%) of shares entitled to vote.
- Amendment effective December 16, 2023; intended to facilitate holding stockholder meetings.
- Full text of amendment filed as Exhibit 3.1 to the Form 8-K.

## SEC filing metadata
- accession: 0001493152-23-045212
- form_type: 8-K
- cik: 0001614067
- company_name: Aridis Pharmaceuticals, Inc.
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1614067/000149315223045212/0001493152-23-045212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1614067/000149315223045212/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-045212
- JSON: https://secwatch.observer/filing/0001493152-23-045212.json
- Plain text: https://secwatch.observer/filing/0001493152-23-045212.txt

## Key facts
- Governance Changes
  Aridis Pharmaceuticals, Inc.: Amended bylaws to change quorum for stockholder meetings to one-third of shares issued and outstanding and entitled to vote (effective 2023-12-16).
  - Change: bylaw amendment
  - Effective: 2023-12-16
  source text: On December 16, 2023, the Board of Directors of Aridis Pharmaceuticals, Inc. (the “Company”) approved an amendment of the Company’s Bylaws (the “Bylaws”) to change the quorum for stockholder meetings to equal one-third (33.33%) of the shares issued and outstanding and entitled to vote on the matters at the meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1614067/000149315223045212/0001493152-23-045212-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.